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ABSTRACT.
Purpose: To determine the correlation between ocular blood ﬂow velocities and
ocular pulse amplitude (OPA) in glaucoma patients using colour Doppler
imaging (CDI) waveform analysis.
Method: A prospective, observer-masked, case-control study was performed.
OPA and blood ﬂow variables from central retinal artery and vein (CRA, CRV),
nasal and temporal short posterior ciliary arteries (NPCA, TPCA) and
ophthalmic artery (OA) were obtained through dynamic contour tonometry
and CDI, respectively. Univariate and multiple regression analyses were
performed to explore the correlations between OPA and retrobulbar CDI
waveform and systemic cardiovascular parameters (blood pressure, blood
pressure amplitude, mean ocular perfusion pressure and peripheral pulse).
Results: One hundred and ninety-two patients were included [healthy controls:
55; primary open-angle glaucoma (POAG): 74; normal-tension glaucoma
(NTG): 63]. OPA was statistically diﬀerent between groups (Healthy:
3.17  1.2 mmHg; NTG: 2.58  1.2 mmHg; POAG: 2.60  1.1 mmHg;
p < 0.01), but not between the glaucoma groups (p = 0.60). Multiple regression
models to explain OPA variance were made for each cohort (healthy:
p < 0.001, r = 0.605; NTG: p = 0.003, r = 0.372; POAG: p < 0.001,
r = 0.412). OPA was independently associated with retrobulbar CDI param-
eters in the healthy subjects and POAG patients (healthy CRV resistance
index: b = 3.37, CI: 0.16–6.59; healthy NPCA mean systolic/diastolic velocity
ratio: b = 1.34, CI: 0.52–2.15; POAG TPCA mean systolic velocity: b = 0.14,
CI 0.05–0.23). OPA in the NTG group was associated with diastolic blood
pressure and pulse rate (b = 0.04, CI: 0.06 to 0.01; b = 0.04, CI: 0.06
to 0.001, respectively).
Conclusions: Vascular-related models provide a better explanation to OPA
variance in healthy individuals than in glaucoma patients. The variables that
inﬂuence OPA seem to be diﬀerent in healthy, POAG and NTG patients.
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open-angle glaucoma – vascular dysregulation
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Introduction
Glaucoma is one of the leading causes
of irreversible blindness in the devel-
oped world (Kingman 2004). Extensive
research is continuously being carried
out both to improve treatment strate-
gies and to uncover the underlying
disease mechanisms. A number of
studies have consistently demonstrated
patients with primary open-angle glau-
coma (POAG) and particularly the
ones with normal-tension glaucoma
(NTG), to have systemic signs of vas-
cular dysfunction. These patients are
more prone to have lower ocular per-
fusion pressures, peripheral vasosp-
asms, migraine, low retrobulbar ﬂow
velocities and decreased ocular pulse
amplitudes (OPA; Wang et al. 1997;
Broadway & Drance 1998; Stalmans
et al. 2008; Leske 2009).
This latter variable (OPA) represents
the amplitude between the systolic and
diastolic intraocular pressure (IOP)
during a cardiac cycle and is measured
at the corneal level by a dynamic
contour tonometer (DCT). It has been
suggested that these IOP ﬂuctuations
reﬂect a change in the choroidal blood
volume (Langham et al. 1989), a tissue
which is supplied by the short posterior
ciliary arteries. Its clinical relevance has
been consistently documented. Indeed,
lower OPA is associated with advanced
stages of the disease, and has been linked
to more progressive forms of glaucoma
(Vulsteke et al. 2008; Kac et al. 2011;
Kynigopoulos et al. 2012). While
these lower OPA readings could be
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related to a decrease in choroidal ﬂow
suggested to exist in glaucoma patients
(Marangoni et al. 2012; Samra et al.
2013), the mechanisms behind these
lower pulse amplitudes remain unclear.
A previous ocular blood ﬂow study
using colour Doppler imaging (CDI)
has suggested that OPA reﬂects vas-
cular resistance of retrobulbar vessels
in healthy individuals, but not in
glaucoma patients (Stalmans et al.
2009). That study, however, assessed
vascular resistance (RI) as a ratio
calculated by only two velocity points
(peak systolic and end-diastolic veloc-
ities) out of the entire Doppler wave-
form pattern. Furthermore, as this
variable has been suggested to have a
nonlinear correlation with the blood
velocity distribution throughout the
cardiac cycle, the information poten-
tially obtained by this variable is
limited (Abeg~ao Pinto et al. 2012c).
Recently, it has been suggested that
more complete Doppler waveform
analysis of the retrobulbar vessels
(including early systolic acceleration,
mean systolic and diastolic ﬂow
velocities and the ratio between those
two) might provide valuable infor-
mation concerning the arteries’ elastic-
ity and compliance and their ability
to buﬀer and accommodate a pulsa-
tile blood ﬂow (Abeg~ao Pinto et al.
2012a).
Our purpose with this study was
therefore to determine whether OPA,
as assessed by DCT, correlates with
these novel retrobulbar blood-ﬂow-
related variables. Additionally, we
explored whether these associations
could provide further insights into




Three cohorts of individuals over
18 years old were recruited for the
study: patients with NTG (n = 63),
patients with POAG (n = 74) and age-
matched healthy controls (n = 55).
This latter group was recruited from
the persons accompanying the patients
(while excluding blood relatives).
Glaucoma patients were deﬁned as
having characteristic optic disc damage
and visual ﬁeld loss (Jampel 1997). For
the diagnosis of POAG, an untreated
IOP of above 21 mmHg or patients
with a formal diagnosis of POAG and
treated with IOP reducing agents
was required. No criteria for the
severity of glaucoma existed other than
the ability to perform a reliable visual
ﬁeld test. Current medical treatment,
including topical IOP-lowering drugs,
was continued. The healthy volunteers
were screened by a glaucoma specialist
(IS) and those with a family history of
glaucoma, an increased or asymmetri-
cal cup/disc ratio or any other optic
disc structural change (notching, disc
haemorrhage), or an IOP above
21 mmHg were considered as glau-
coma suspects and excluded. Subjects
in all cohorts with a history of ocular
trauma or eye disease (including high
ametropias, deﬁned as hyperopia >4Dp
and myopia >6Dp) were excluded.
Diabetic patients and all forms of
secondary glaucomas (including
pseudo-exfoliative) were also excluded
from the study.
Measuring devices
Intraocular pressure was measured
with Goldmann applanation tonometer
(GAT) and dynamic contour tonome-
try (DCT – Pascal, Ziemer Ophthal-
mic System AG, Port, Switzerland),
with OPA being recorded from this
latter tonometry reading. OPA read-
ings were repeated twice, and the aver-
age between two measurements was
considered. Only quality readings of 2
or less were considered. Central corneal
thickness (CCT) was measured using a
Pachmate DGH55 (DGH Technology
Inc., Exton, PA, USA). Retrobulbar
Doppler waveforms of the central ret-
inal vessels (artery and vein, CRA and
CRV, respectively), short posterior cil-
iary arteries (nasal and temporal,
NPCA and TPCA, respectively) and
ophthalmic artery (OA) were obtained
with the Antares CDI device (Siemens,
Munich, Germany). To increase the
visibility of the dicrotic notch in each
artery, the pulse repetition frequency
was adjusted so as to maximize the
dimensions of waveform. Visual acuity
was tested using the Early Treatment of
Diabetic Retinopathy Study (ETDRS)
chart placed in the same location at the
same distance from the patient under
the same illumination for all subjects.
Blood pressure measurement was taken
from subject’s right arm using an
electronic sphygmomanometer (Om-
ron, Schaumburg, IL, USA).
Experimental design
In this prospective, observer-masked,
case-control study, patients were
instructed to avoid caﬀeine intake,
smoking, and exercise for 3 hr prior
to the study visit. The study was
approved by the ethical review com-
mittee (institutional review board) at
the University Hospitals Leuven and
was conducted in accordance with
good clinical practice within the tenets
of the Declaration of Helsinki. Each
patient/subject was required to sign an
informed consent statement before
being enrolled into the study and prior
to any study measurements being
taken. During the study visit, the fol-
lowing examinations were performed in
the same order: visual acuity, IOP
measurement by GAT and DCT,
pachymetry, blood pressure and
peripheral pulse rate measurements
and ﬁnally CDI. All CDI measure-
ments were performed according to the
published consensus methodology
(Stalmans et al. 2011) by a single
observer (LAP) masked to the patient
diagnosis. An oﬄine analysis of the
waveform analysis was performed in all
the retrobulbar arteries (CRA, NPCA,
TPCA and OA) by the same observer
to determine the following variables
(Fig. 1): acceleration (Acc), systolic
and diastolic mean velocities (Sm and
Dm) and their ratio (Sm/Dm), peak
systolic and end-diastolic velocity
(PSV and EDV), resistance index (RI)
and mean ﬂow velocities (MFV) as
described elsewhere (Abeg~ao Pinto
et al. 2012a). The following variables
were analysed in the central retinal
vein: maximal and minimal velocity
(Vmax and Vmin, respectively) and RI
(Fig. 1). Only one eye per patient was
included in the study. The eye with
greater glaucomatous damage was
selected in the glaucoma patients and
a randomly selected eye in the healthy
individuals.
This study has been registered in the
clinicaltrial.gov (NCT01840202).
Statistical methodology
Normality tests (D’Agostino & Pear-
son omnibus) were performed, with
nonlinear regression models (Gaussian
curves) designed to characterize OPA
distribution in each cohort. Kruskal–
Wallis with Dunn’s correction for pair-
wise comparison tests were used to
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compare the means between the three
diagnostic groups. The existence of cor-
relation between variables was explored
using Spearman’s correlation. Multiple
regression analyses were performed to
identify independent associations to
OPA. Statistical signiﬁcance was con-
sidered when two-sided p value < 0.05.




Table 1 summarizes the patient char-
acteristics in the diﬀerent cohorts with
their comparative p values. No diﬀer-
ences were observed in age, visual
acuity, central corneal thickness, blood
pressure variables (systolic, diastolic,
amplitude and mean ocular perfusion
pressures) and peripheral pulse (p
range between 0.08 and 0.85). IOP
was signiﬁcantly diﬀerent (p = 0.02),
with lower values in the NTG group
when compared to both healthy and
POAG groups (versus healthy
p = 0.03; versus POAG p < 0.01), but
no diﬀerence in IOP between these two
latter groups (p = 0.70).
Ocular pulse amplitudewas statistically
diﬀerent between the cohorts (healthy:
3.17  1.2 mmHg; NTG: 2.58 
1.2 mmHg; POAG: 2.60  1.1 mmHg;
p < 0.01). Both glaucoma groups had
lower OPA when compared to the
healthy cohort (versus NTG p = <0.01;
versus POAG p < 0.01), but no diﬀer-
encewas detected between theNTGand
POAG groups (p = 0.60). Figure 2
illustrates the frequency distribution
(and the corresponding Gaussian
curves) of OPA in the three cohorts.
Retrobulbar Doppler waveform analysis
Table 2 depicts the retrobulbar Dopp-
ler waveform variables for each cohort.
Flow velocities in the CRA, CRV,
TPCA and OA were reduced in both
glaucoma groups when compared to
healthy individuals (p < 0.05). Of the
entire Doppler parameters, only the
CRA’s EDV (p = 0.01) and each of
the venous ﬂow parameters (p < 0.04
in all comparisons) were statistically
diﬀerent between the two glaucoma
cohorts.
Relationship between OPA and Ocular
and Systemic vascular parameters
Table 3 illustrates the univariate statis-
tically signiﬁcant associations between
ocular and systemic parameters and
OPA. The Doppler-related variables
that did not have a statistical correla-
tion with OPA in any of the three
groups were not represented.
Multiple regression analysis models
were constructed for each of the
cohorts, using OPA as the dependent
parameter and all those parameters
that were signiﬁcantly associated with
Table 1. Patients characteristics.
Healthy NTG POAG Kruskal–Wallis
N 55 63 74
Age (years) 65.1  11.0 69.7  9.0 67.4  10.7 0.08
IOP (mmHg) 17.1  3.3 15.6  2.8 17.5  4.2 0.02
Visual acuity (logMar) 0.14  0.2 0.17  0.3 0.10  0.2 0.37
MD (dB) – 9.8  8.6 10.9  8.9 0.49
CCT (lm) 557  39.6 541  42.2 548  37.1 0.34
Systolic BP (mmHg) 150.0  19.4 150.3  24.9 152.1  20.2 0.59
Diastolic BP (mmHg) 82.8  11.9 83.7  12.2 86.0  11.8 0.22
BP amplitude (mmHg) 66.6  16.8 66.6  22.9 66.1  16.9 0.85
MOPP (mmHg) 53.5  9.6 55.9  10.3 54.4  9.8 0.40
Pulse (bpm) 69.3  9.8 63.4  12.8 69.9  12.6 0.10
Mean values (and SD) are depicted. Kruskal–Wallis indicates p values of overall diﬀerences
between the diagnostic groups. IOP indicates intraocular pressure; MD, mean defect; CCT, central
corneal thickness; BP, blood pressure; and MOPP, mean ocular perfusion pressure [(2/3




Fig. 1. Doppler waveform of the central reti-
nal artery and vein (A), the short ciliary
arteries, both nasal and temporal (B) and the
ophthalmic artery (C). Acc represents the
fastest moving portion of the systolic compo-
nent; PSV, the peak systolic velocity; EDV, the
end-diastolic velocity; and Sm and Dm, the
mean systolic and diastolic velocity, respec-
tively.
























Fig. 2. Frequency distribution of OPA in the three experimental groups (in percentage). Despite
similar absolute means with the primary open-angle glaucoma (POAG) group, the Gaussian
distribution of NTG shows a smaller, left-oriented OPA curve. Considering 0.5 mmHg intervals,
the median OPA in NTG was 2.0 mmHg (23.8%) while in POAG and healthy groups was
3.0 mmHg (23.0%) and 4.0 mmHg (20%), respectively. Data points refer to healthy (circles),
POAG (triangles) and NTG (squares).
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OPA in univariate analysis as indepen-
dent variables. Multicollinearity in
each model was corrected until the
highest possible model ﬁt was achieved.
All three models were statistically
signiﬁcant in explaining OPA variance,
with a higher degree of correlation in
the healthy group than in either of the
glaucoma cohorts (healthy p < 0.001,
r = 0.605; NTG p = 0.003, r = 0.372;
POAG p < 0.001, r = 0.412; Table 4).
The diﬀerence in coeﬃcient correla-
tions between the healthy and the
glaucoma models was borderline sig-
niﬁcant (one-sided P Fisher r-to-z
transformation: healthy versus POAG:
p = 0.07; healthy versus NTG:
p = 0.05). The independent variables
were diﬀerent for each group. While
OPA in the healthy and POAG groups
was independently associated with ret-
robulbar ﬂow variables (healthy: CRV
RI: b = 3.37, CI: 0.16–6.59; NPCA Sm/
Dm: b = 1.34, CI: 0.52–2.15; POAG:
IOP b = 0.13, CI 0.07–0.20, TPCA Sm
b = 0.14, CI 0.05–0.23; respectively),
OPA in the NTG group was rather
associated with systemic variables such
as diastolic blood pressure and pulse
rate (b = 0.04, CI:0.06 to 0.01;
b = 0.04, CI: 0.06 to 0.001;
respectively).
Discussion
The current study showed that the
parameters obtained from a detailed
Doppler waveform analysis signiﬁ-
cantly associated with OPA. In fact,
once the entire Doppler waveform
spectrum was taken into account, none
of the classic CDI-studied variables
(such as PSV, EDV or arterial RI)
were independently associated with
OPA. Accordingly, analysing time-con-
tinuous variables such as systolic or
diastolic mean ﬂows may better explain
OPA ﬂuctuations than a classic two-
point assessment of the retrobulbar
haemodynamics.
The strength of correlation of our
constructed vascular-orientated models
diﬀers between healthy and glaucoma
groups, with a weaker correlation
between OPA and the ocular and
systemic vascular parameters in both
POAG and NTG. This would suggest
that in glaucoma patients, other non-
vascular variables may be important
determinants of OPA. These variables
could relate to diﬀerences in ocular
elasticity and compliance between glau-
coma patients and healthy individuals
as suggested by several authors (Sigal
et al. 2005; Hommer et al. 2008; Das-
tiridou et al. 2013; Wang et al. 2013).
For instance, any determined increase
in intraocular blood volume would lead
to a smaller increase in pressure if the
overall compartment is elastic rather
than rigid. Accordingly, the lower
readings in OPA by an external tonom-
eter (such as the DCT) found in glau-
coma patients could be related to the
mechanical properties of the ocular
compartment walls (for instance, a
more elastic sclera). Furthermore, from
a structural point of view, for the
choroidal-related pressure pulse to
reach the cornea, it must go through
a number of tissues. Accordingly, these
structural properties of all those tissues
(vitreous, lens, iris, aqueous humour
and the cornea) could buﬀer that wave
pulse. Our results would thus suggest
that the summation of the input from
all these structures in generating OPA
are more relevant in glaucoma patients
Table 2. Comparison of Doppler waveform variables between diagnostic groups.
Healthy (n = 55) NTG (n = 63) POAG (n = 74) Overall NTG versus POAG
CRA
Acc 160  66 127  57 127  66 <0.002 0.27
PSV 12.9  4.4 10.6  3.5 9.63  3.6 <0.001 0.07
EDV 3.55  1.3 2.88  0.9 2.63  0.8 <0.001 0.01
MFV 6.88  2.5 5.55  1.8 5.16  2.0 <0.001 0.11
RI 0.72  0.1 0.71  0.1 0.71  0.1 0.88 0.87
Sm 11.0  4.1 8.85  3.1 8.14  3.1 <0.001 0.12
Dm 4.99  1.9 3.85  1.3 3.64  1.3 <0.001 0.22
Sm/Dm 2.27  0.5 2.33  0.5 2.27  0.5 0.52 0.43
CRV
Vmax 5.97  1.7 5.19  1.4 4.51  1.3 <0.001 <0.001
Vmin 3.45  0.9 3.02  0.6 2.84  0.7 <0.001 0.04
RI 0.41  0.1 0.39  0.1 0.35  0.1 <0.004 0.03
NPCA
Acc 128  49 103  40 112  52 0.03 0.63
PSV 10.8  4.1 9.52  3.0 9.17  2.8 0.08 0.58
EDV 3.81  1.7 3.33  1.2 3.00  0.9 0.02 0.10
MFV 6.39  2.9 5.61  1.9 5.29  1.6 0.14 0.42
RI 0.65  0.1 0.64  0.1 0.66  0.1 0.24 0.13
Sm 8.84  3.1 8.08  2.7 7.67  2.4 0.11 0.40
Dm 4.72  2.0 4.27  1.6 3.96  1.3 0.12 0.30
Sm/Dm 1.97  0.4 1.94  0.3 1.96  0.3 0.58 0.56
TPCA
Acc 128  58 115  49 127  47 0.22 0.11
PSV 11.1  3.7 9.54  3.3 9.80  2.9 0.01 0.30
EDV 3.80  1.4 3.22  1.2 3.19  1.1 <0.006 0.70
MFV 6.74  2.3 5.62  2.2 5.65  1.8 <0.003 0.44
RI 0.65  0.1 0.66  0.1 0.67  0.1 0.16 0.24
Sm 9.49  2.8 8.13  2.8 8.39  2.5 <0.005 0.28
Dm 5.11  1.7 4.14  1.6 4.30  1.6 <0.002 0.44
Sm/Dm 1.91  0.4 2.01  0.3 2.02  0.4 0.04 0.80
OA
Acc 599  310 492  233 462  173 0.02 0.58
PSV 39.7  17 32.9  10 31.2  10 <0.002 0.20
EDV 7.96  4.6 6.03  3.8 5.96  3.1 <0.007 0.83
MFV 18.0  8.5 14.8  6.4 14.2  5.9 0.01 0.73
RI 0.80  0.1 0.82  0.1 0.81  0.1 0.25 0.27
Sm 30.2  14 25.9  8.9 24.7  8.6 0.03 0.44
Dm 11.9  6.6 9.45  5.2 9.10  4.5 <0.007 0.91
Sm/Dm 2.79  1.1 3.13  1.2 3.07  1.2 0.15 0.54
Kruskal–Wallis test with Dunn’s correction was used in the overall and pairwise comparison
between cohorts. NTG indicates normal-tension glaucoma; POAG, primary open-angle
glaucoma; CRA, central retinal artery; CRV, central retinal vein; NPCA, nasal posterior ciliary
arteries; TPCA, temporal posterior ciliary arteries; OA, ophthalmic artery; Acc, acceleration speed
(cm/seg2); PSV, peak systolic velocity (cm/seg); EDV, end-diastolic velocity (cm/seg); MFV, mean
ﬂow velocity (cm/seg); Sm, mean systolic velocity (cm/seg); Dm, mean diastolic velocity (cm/seg);




than in healthy individuals (as the
vascular models – while signiﬁcant –
explain a smaller degree of OPA var-
iance than in healthy controls). Recent
advances in optical coherent tomogra-
phy (OCT) technology, which allow
in vivo mapping of the scleral thickness,
may provide further insight into this
discussion (Park et al. 2012). More
studies will be needed to determine
whether the diﬀerences in the correla-
tion of OPA and ocular-related vari-
ables between healthy and glaucoma
patients might be related to such
structural diﬀerences.
Interestingly, our results also suggest
that under physiological conditions (i.e.
healthy eyes), the RI of the CRV would
be involved in OPA. While it would be
intuitive that a relation should exist
between the arterial blood input and
venous output, the retinal circulation is
only responsible for a small portion of
the overall blood volume. However, as
the CRV is a low pressure system, the
ﬂuctuations in pressure inside the eye
(OPA) may directly inﬂuence venous
output (Donnelly & Subramanian 2009;
Abeg~ao Pinto et al. 2012b). Both
POAG and NTG patients are thought
to have a higher-than-expected intralu-
minal venous pressure (Morgan et al.
2004). Therefore, this compression
caused by the pulsatile choroidal ﬂow
would be unlikely to impact the retinal
venous output in glaucoma patients,
which may explain why the association
between OPA and CRV RI was not
present in these patient groups.
In NTG patients, there are no direct
associations between local ocular-
related factors and OPA. Even the
independent statistically associated
variables have a low correlation coef-
ﬁcient on the overall OPA detection.
However, the fact that blood pressure
and heart rate parameters can signiﬁ-
cantly inﬂuence OPA would imply that
the local vascular auto-regulation is no
longer able to compensate for these
changes. Indeed, within the limits of
our study population, in healthy and
even POAG patients, the ocular blood
ﬂow appears to be able to buﬀer the
inﬂuence of the systemic cardiovascular
parameters. This is in line with a
number of studies on ocular blood ﬂow
in glaucoma patients, where NTG
patients show signs of abnormal vas-
cular regulation ability (Gherghel et al.
2000; Galassi et al. 2011).
Our study has limitations. Systemic
antihypertensive medication was not
withheld for this study, which may have
introduced a confounding factor in all
three groups. On ethical grounds, it was
deemed excessive to withdraw impor-
tant medication in a study where no
direct beneﬁt could come to the patient.
For this reason, this is a common
limitation of observational studies in
elderly patients (where a number of
comorbidities are likely to exist). Sec-
ondly, as illustrated inFig. 2, theGauss-
ian curve in NTG shows a smaller range
in OPA values. While expected, it is
therefore not unusual that smaller cor-
relation coeﬃcients with other variables
were detected in this narrow frequency
distribution. Further studies involving
Table 3. Univariate correlations with OPA in the three cohorts.
Healthy (r) POAG (r) NTG (r)
Age – – –
CCT – – –
IOP 0.28 0.56 –
CRA – Acc 0.30 – –
CRA – Sm/Dm 0.32 0.34 0.47
CRA – RI – 0.31 0.37
CRV – Vmax – – 0.28
CRV – RI 0.32 – 0.41
NPCA – Sm/Dm 0.41 – 0.33
NPCA – RI 0.30 – –
TPCA – Acc – 0.27 –
TPCA – PSV – 0.28 –
TPCA – Sm – 0.27 –
TPCA – Sm/Dm 0.35 0.24 –
TPCA – RI 0.31 0.30 –
OA – PSV 0.26 – –
OA – Sm – 0.31 –
OA – MFV – 0.27 –
OA – Sm/Dm 0.19 0.01 –
MOPP – – 0.29
Systolic BP – – –
Diastolic BP – – 0.44
BP Amp 0.40 – 0.36
Pulse – – 0.53
r values depicted if p < 0.05. The remaining Doppler-related variables that are not represented did
not have a statistical correlation with OPA. POAG indicates primary open-angle glaucoma; NTG,
normal-tension glaucoma; CCT, central corneal thickness; IOP, intraocular pressure; CRA,
central retinal artery; NPCA, nasal posterior ciliary artery; TPCA, temporal posterior ciliary
artery; OA, ophthalmic artery; MOPP, mean ocular perfusion pressure [(2/3 diastolic+1/3 systolic
BPs)*2/3-Goldmann tonometry]; BP, blood pressure; BP Amp, blood pressure amplitude (BP
systolic – BP diastolic);Acc, acceleration speed; PSV, peak systolic velocity; MFV, mean ﬂow
velocity; Sm, mean systolic velocity; Dm, mean diastolic velocity; Vmax, maximal venous velocity;
and RI, resistivity index.
Table 4. Multiple regression models and its independent-related variables for each of the cohorts.
Variable p value b coeﬃcient Conﬁdence interval
Healthy (r = 0.61, p < 0.001) CRV RI 0.04 3.37 0.16 to 6.59
NPCA Sm/Dm 0.002 1.34 0.52 to 2.15
POAG (r = 0.41, p < 0.001) IOP <0.001 0.13 0.07 to 0.20
TPCA Sm 0.003 0.14 0.05 to 0.23
NTG (r = 0.37, p = 0.003) Diastolic BP 0.007 0.04 0.06 to 0.01
Pulse 0.04 0.04 0.06 to 0.001
Data representing the following linear models: Healthy = 2.531 + 0.06782*IOP + 0.002841
*CRA Acc  0.7433*CRA Sm/Dm + 3.374*CRV RI + 1.335*NPCA Sm/Dm + 1.978*TPCA
RI + 0.02307*OA MFV + 0.002581*BP amp; POAG = 3.313 + 0.1329*IOP + 0.2456*CRA
Sm/Dm+ 3.599*CRA RI  0.001070*TPCA Acc + 0.1383*TPCA Sm  0.4831*TPCA Sm/
Dm + 0.02498*OA Sm  0.01092*OA MFV; NTG = 8.019 + 0.3371*CRA Sm/Dm  2.621*CRA




analysis of non-vascular-related vari-
ables may help further explain this
smaller OPA variance in glaucoma
patients. For instance, by combining
other ocular blood ﬂow technologies
that enable the accurate calculation of
volume change (such as the Langham
ocular blood ﬂow system, laser interfer-
ometry or subfoveal laser Doppler ﬂow-
metry), information on diﬀerences in
ocular rigidity can be added to the
current CDI-based analysis.
In conclusion, our study aimed at
exploring whether an association
between the blood volume change nec-
essary to produce a pulse pressure inside
the eye and the blood velocity in the
arteries that nurture the eye existed. The
answers to this – as the results from the
current study suggests – could vary
between healthy and glaucoma groups,
thus implying OPA readings could rep-
resent a balance in the forces involved
that may vary according to each patient
(healthy, NTG or POAG). Neverthe-
less, our results seem to suggest that
OPA variance is more strongly inﬂu-
enced by vascular-related factors in
healthy individuals than in glaucoma
patients. The smaller OPA values in
glaucoma patients may therefore relate
to diﬀerences in non-vascular variables.
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